Inspire Medical Systems, Inc. (NYSE:INSP) Q2 2024 Earnings Conference Call August 6, 2024 5:00 PM ET
Company Participants
Ezgi Yagci - Vice President of Investor Relations
Tim Herbert - Chairman and Chief Executive Officer
Rick Buchholz - Chief Financial Officer
Conference Call Participants
Robbie Marcus - JPMorgan
Richard Newitter - Truist Securities
Adam Maeder - Piper Sandler
Anthony Petrone - Mizuho Group
Danielle Antalffy - UBS
Michael Sarcone - Jefferies
Chris Pasquale - Nephron Research
Brett Fishbin - KeyBanc Capital Markets
David Rescott - Baird
Shagun Singh - RBC Capital Markets
Larry Biegelsen - Wells Fargo
Kallum Titchmarsh - Morgan Stanley
Michael Polark - Wolfe Research
Jon Block - Stifel
Mike Kratky - Leerink Partners
Suraj Kalia - Oppenheimer & Co
Travis Steed - Bank of America
Operator
Good afternoon. My name is Dilem, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Inspire Medical Systems Second Quarter 2024 Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session.
I'll now hand the call over to your first speaker, Ezgi Yagci, the Vice President of Investor Relations at Inspire. You may begin the conference.
Ezgi Yagci
Thank you, Dilem, and thank you all for participating in today's call. Joining me are Tim Herbert, Chairman and Chief Executive Officer; and Rick Buchholz, Chief Financial Officer. Earlier today, we released financial results for the 3 and 6 months ended June 30, 2024. A copy of the press release is available on our website.
On this call, management will make forward-looking statements within the meaning of the federal securities laws. All forward-looking statements, including, without limitation, those relating to our operations, financial results and financial investments in our business, full-year 2024 financial and operational outlook and changes in market access are based upon our current estimates and various assumptions.
These statements involve material risks and uncertainties that could cause actual results or events to materially differ. Accordingly, you should not place undue reliance on these statements. Please see our filings with the Securities and Exchange Commission, including our Form 10-Q, which we filed with the SEC earlier this afternoon for a description of these risks and uncertainties. Inspire disclaims any intention or obligation, except as required by law, to update or revise any financial projections or forward-looking statements whether because of new information, future events or otherwise. This conference call contains time-sensitive information and speaks only as of the live broadcast today, August 6, 2024.